Skip to main content
Terug
Watch Compare

WORK Medical Technology Group LTD

Datakwaliteit: 83%
WOK
NASDAQ Manufacturing Measuring & Analyzing Instruments
€ 1,17
▲ € 0,01 (0,86%)
6 months return
—
Momentum
Neutral
ROE
-6,81%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-6,81%
Boven sectorgemiddelde (-54,47%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
1,00
Boven sectorgemiddelde (0,30)
Current Ratio1,14
Interest CoverageN/A

Waardering

PE (TTM)
-1,40
Boven sectorgemiddelde (-1,50)
P/B Ratio0,12
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Generating 4,91 M in free cash flow

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -6,81% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -1,07 M
ROE -6,81% ROA -3,09%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 4,91 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: 1,00 · Current: 1,14
Debt / Equity 1,00 Current Ratio 1,14
Interest Coverage N/A Asset Turnover N/A
Working Capital 2,60 M Tangible Book Value 11,97 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -1,40 · EV/EBITDA: N/A
P/E Ratio -1,40 Forward P/E N/A
P/B Ratio 0,12 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 326,74%
Market Cap 1,50 M Enterprise Value 12,39 M

Per Share

EPS: -0,04 · FCF/Share: 3,79
EPS (Diluted TTM) -0,04 Revenue / Share N/A
FCF / Share 3,79 OCF / Share 4,82
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -457,90% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion -457,90%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -1,07 M -3,49 M
EPS (Diluted) -0,04 -0,27
Gross Profit 2,34 M 2,87 M
Operating Income — —
EBITDA — —
R&D Expenses 435.311,0 302.511,0
SG&A Expenses — —
D&A 923.108,0 1,41 M
Interest Expense 503.519,0 557.571,0
Income Tax 119.053,0 -125.291,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 33,16 M 36,25 M
Total Liabilities 11,99 M 20,18 M
Shareholders' Equity 18,34 M 13,19 M
Total Debt 6,39 M 13,32 M
Cash & Equivalents 4,09 M 6,56 M
Current Assets 20,46 M 20,83 M
Current Liabilities 11,97 M 20,18 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -1,4 -1,5
P/B 0,1 1,6
ROE % -6,8 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,7
D/E 1,0 0,3